Brookline Capital Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $9

Futu NewsDec 19 18:33 · Ratings

Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours

MT NewswiresDec 19 06:48

Express News | Quince Therapeutics: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

BreakingsDec 19 05:04

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaDec 18 23:03

Brookline Capital Initiates Coverage On Quince Therapeutics With Buy Rating, Announces Price Target of $9

BenzingaDec 18 20:48 · Ratings

Quince Therapeutics Analyst Ratings

BenzingaDec 18 20:45 · Ratings